Glycoside cleavage reactions on erythromycin A. Preparation of erythronolide A.
D000617:Aminoglycosides; D000818:Animals; D001410:Bacillus megaterium / Q000187:drug effects; D002942:Circular Dichroism; D004754:Enterobacter / Q000187:drug effects; D004917:Erythromycin / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000494:pharmacology / Q000627:therapeutic use; D004926:Escherichia coli / Q000187:drug effects; D004927:Escherichia coli Infections / Q000188:drug therapy; D013058:Mass Spectrometry; D051379:Mice; D008826:Microbial Sensitivity Tests; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D012441:Saccharomyces cerevisiae / Q000187:drug effects; D012505:Sarcina / Q000187:drug effects; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy
D000617:Aminoglycosides; D004917:Erythromycin